Capricor Therapeutics (CAPR) released expectation-beating results for the fourth quarter, sending the shares up over 5% in aftermarket trading.

Market Cap: $95.6 billion Key Focus: mRNA therapeutics and vaccines Latest Innovations: Next-generation COVID-19 vaccines, personalized cancer vaccines Moderna has solidified its position as a leader ...

When it comes to recipes, I have a few nonnegotiables: simple, healthy and delicious! These creations are terrific for when you’re craving a quick breakfast or scrumptious afternoon snack: my ...

A high throughput screen of >30,000 diverse repressor domains from across the tree of life identifies repressor domains with unique structures that underpin enhanced epigenetic effector domain ...

Scotiabank initiated coverage of Perspective Therapeutics (CATX) with an Outperform rating and $15 price target The firm says Perspective Therapeutics is one of the few remaining independent ...

TRIMTECH Therapeutics, a biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, today announced the closing of its $31 million (£25 million ...

An icon of 3 horizontal dots. An icon of a paper envelope. An icon of a facebook f logo. An icon of a digital camera. An icon of a house. An icon of the Instagram logo. An icon of the LinkedIn logo.

SANTA CRUZ, Calif., March 6, 2025 /PRNewswire/ -- Capstan Medical, a developer of robotic-enabled minimally invasive solutions to address heart valve disease, announced today the successful ...

Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology and programs exclusively in-licensed from Singapore-based Hummingbird Bioscience ...

Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology and programs exclusively in-licensed from Singapore-based Hummingbird Bioscience Financing ...